858.450.2800info@Sudoscan.com
SUDOSCAN® User LOGIN
Estimating the Risk of Cardiac Autonomic Neuropathy in Chinese Subject Passer au contenu
  • About SUDOSCAN®
  • Our Company
  • Research, Media & Events
  • Contact
  • SUDOSCAN® Shop
  • Supplies
  • Se connecter
  • YouTube
Panier


Sous-total
$0.00
Les codes promo, les frais d'envoi et les taxes seront ajoutés à la caisse.
Votre panier est vide.
SUDOSCAN Logo Powered by Withings SUDOSCAN Logo Powered by Withings Sudoscan Logo white SUDOSCAN Logo Powered by Withings
  • About SUDOSCAN®
  • Our Company
  • Research, Media & Events
  • Contact
  • SUDOSCAN® Shop
  • Supplies
Se connecter Panier
Create Account
Schedule an online DEMO

Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts
Accueil / Research, Media & Events / Estimating the Risk of Cardiac Autonomic Neuropathy in Chinese Subjects through Sudomotor Function and Arterial Stiffness
Cardiac Autonomic Neuropathy · Scientific publications · 18 février, 2023

Estimating the Risk of Cardiac Autonomic Neuropathy in Chinese Subjects through Sudomotor Function and Arterial Stiffness

Estimating the Risk of Cardiac Autonomic Neuropathy

Zeng Q, Dong SY, Wang ML, Wang F, Li JM, Zhao XL.

J Hum Hypertens. 2016 Jan 7. doi: 10.1038/jhh.2015.126.

Abstract

The aim of this study was to investigate the association between cardiac autonomic neuropathy (CAN) risk score estimated by the SUDOSCAN test and arterial stiffness. The study included 4019 subjects without diabetes or established cardiovascular disease. The hands and feet mean electrochemical skin conductance (ESC) measured by SUDOSCAN were 70±17 μS and 71±16 μS, respectively, and the CAN risk score was 21±10%. The levels of central systolic blood pressure (cSBP) and brachial-ankle pulse wave velocity (baPWV) increased as the CAN risk score quartiles increased (P for trend <0.001 for all). Spearman correlation analyses showed that the CAN risk score was positively correlated with cSBP (r=0.391, P<0.001) and baPWV (r=0.305, P<0.001). Multivariable analyses showed that the values of cSBP and baPWV increased 0.17 mm Hg (P=0.002) and 2.01 cm per second (P=0.010), respectively, for every 1% increase in CAN risk score. The association remained unchanged when stratified by glucose tolerance status. In conclusion, the study found that cardiac autonomic dysfunction estimated by sudomotor function was positively associated with arterial stiffness, independent of conventional factors and glucose tolerance status.

Partager Partager sur Facebook Tweeter Tweeter sur Twitter Épingler Épingler sur Pinterest

Retour à Research, Media & Events
Invalid password
Enter
Sudoscan Logo

SUDOSCAN® is a privately-owned French medical device company.

Created in June 2005, SUDOSCAN is located in San Diego, CA, USA; the company's corporate headquarters are in Paris, France. We service all of the North and South America, The Middle East, Europe and Asia.

  • YouTube

Sudoscan

  • About SUDOSCAN®
  • Our Company
  • Research, Media & Events
  • Contact
  • SUDOSCAN® Shop
  • Supplies

Shop SUDOSCAN

  • Login
  • Create an account
  • SUDOSCAN® Shop
  • Electrodes

Resources

  • For Patients
  • For Physicians
  • SUDOSCAN® Articles
  • SUDOSCAN® Videos
  • SUDOSCAN® Image Gallery
  • Reimbursement Regulatory

CONTACT INFO:

US TERRITORIES:
SUDOSCAN Inc.
8525 Gibbs Dr. Suite 304
San Diego, CA 92123

Phone: +1 858 450 2800

INTERNATIONAL:
Impeto Medical
2 Rue Maurice Hartmann,
92130 Issy-les-Moulineaux,
France

Phone: +33 (0)7 87 20 32 03
Website: www.impeto-medical.com/

Promotional Communication. The medical devices SUDOSCAN® is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 05/10/2023

Langue

  • English
  • Français

Devise

  • Canada (CAD $)
  • États-Unis (USD $)
  • American Express
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • Shop Pay
  • Visa
© 2023 SUDOSCAN USA | Autonomic & Sudomotor Testing Device Web Development
Estimating the Risk of Cardiac Autonomic Neuropathy in Chinese Subject